Why lifestyle medicine?

Lifestyle Medicine: A Manual for Clinical Practice

Volumn , Issue , 2016, Pages 1-8

  Mechanick, Jeffrey I ^a   Kushner, Robert F ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chronic disease; Disease complexity; Health promotion; Lifestyle medicine; Preventive medicine

Indexed keywords

EID: 85169381437     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-24687-1_1     Document Type: Chapter

References (80)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014. doi:10.1161/01.cir.0000441139.02102.80. Accessed 22 June 2014.
2. CDC. Million hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors-United States, 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1248-51.
3. Centers for Disease Control and Prevention. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation- United States, 2010-2012. MMWR Morb Mortal Wkly Rep. 2013;62:869-92.
4. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-47.
5. Alzheimer's Association. Alzheimer's facts and figures. 2015. http://www.alz.org/alzheimers_disease_facts_and_figures.asp#prevalence. Accessed 22 June 2014.
6. Wright NC, Looker AC, Saag KG, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Mineral Res. 2014. doi:10.1002/jbmr.2269.
7. CDC. National Diabetes Statistics Report. 2014. http://www.cdc. gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed 22 June 2014.
8. CDC. Current depression among adults-United States, 2006 and 2008. MMWR Morb Mortal Wkly Rep. 2010;59:1229-35.
9. American Lung Association, Epidemiology and Statistics Unit. Estimated prevalence and incidence of lung disease. 2014. http://www.lung.org/finding-cures/our-research/trend-reports/estimated-prevalence.pdf. Accessed 22 June 2014.
10. De Moor JS, Mariotto AB, Parry C, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Canc Epidemiol Biomark Prev. 2013;22:561-70.
11. CDC. Diagnoses of HIV infection in the United States and Dependent Areas. 2011. http://www.cdc.gov/hiv/library/reports/surveillance/2011/surveillance:Report_vol_23.html#3. Accessed 22 June 2014.
12. Perrin EC, Newacheck P, Pless IB, et al. Issues involved in the definition and classification of chronic health conditions. Pediatrics. 1993;91:787-93.
13. O'Halloran J, Miller GC, Britt H. Defining chronic conditions for primary care with ICPC-2. Fam Pract. 2004;21:381-6.
14. CDC. Chronic disease and health promotion. 2015. http://cdc.gov/ chronicdisease/overview/index.htm. Accessed 18 July 2014.
15. CDC. Healthy people 2020. 2011. http://www.cdc.gov/nchs/ healthy_people/hp2020.htm. Accessed 22 June 2014.
16. CDC. CDC grand rounds: childhood obesity in the United States. MMWR Morb Mortal Wkly Rep. 2011;60:42-6.
17. Chung A, Backholer K, Wong E, et al. Trends in child and adolescent obesity prevalence according to socioeconomic position: protocol for a systematic review. Systematic Rev. 2014;3:52-6.
18. CDC. Awareness of prediabetes-United States, 2005-2010. MMWR. 2013;62:209-12.
19. Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diab Res Clin Pract. 2014;103:137-49.
20. Slack T, Myers CA, Martin CK, et al. The geographic concentration of US adult obesity prevalence and associated social, economic, and environmental factors. Obesity. 2014;22:868-74.
21. Eilerman PA, Herzog CM, Luce BK, et al. A comparison of obesity prevalence: military health system and United States populations, 2009-2012. Military Med. 2014;179:462-70.
22. Thomas DM, Weedermann M, Fuenmeler BF, et al. Dynamic model predicting overweight, obesity, and extreme obesity prevalence trends. Obesity. 2014;22:590-7.
23. CDC. Obesity-United States, 1999-2010. MMWR Surveill Summ. 2013;62:120-8.
24. Ostbye T, Stroo M, Eisenstein EL, et al. Is overweight and class I obesity associated with increased health claims costs? Obesity. 2014;22:1179-86.
25. Tarleton HP, Ryan-Ibarra S, Induni M. Chronic disease burden among cancer survivors in the California behavorial risk factor surveillance system, 2009-2010. J Cancer Surviv. 2014. doi:10.1007/ s11764-014-0350-x.
26. Forster M, Veeman JL, Barendregt JJ, et al. Cost-effectiveness of diet and exercise interventions to reduce overweight and obesity. Int J Obes (Lond). 2011;35:1071-8.
27. Devleesschauwer B, Havelaar AH, Maertens de Noordhout C, et al. Calculating disability-adjusted life years to quantify burden of disease. Int J Public Health. 2014;59:565-9.
28. Larson BA. Calculating disability-adjusted-life-years lost (DALYs) in discrete time. Cost Eff Res Alloc. 2013;11:18-24.
29. Polinder S, Haagsma JA, Stein C, et al. Systematic review of general burden of disease using disability-adjusted life years. Popul Health Metr. 2012;10:21-36.
30. Schroeder SA. Incidence, prevalence, and hybrid approaches to calculating disability-adjusted life years. Popul Health Metr. 2012;10:19-26.
31. Struijk EA, May AM, Beulens JWJ, et al. Development of methodology for disability-adjusted life years (DALYs) calculation based on real-life data. PloS ONE. 2014;8:e74294. doi:10.1371/journal. pone.0074294.
32. Gibney K, Sinclair M, O'Toole J, et al. Using disability-adjusted life years to set health-based targets: a novel use of an established burden of disease metric. J Public Health Policy. 2013;34:439-46.
33. Murray CJ, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and profected to 2020. Cambridge: Harvard University Press; 1996.
34. Lopez AD, Mathers CD, Ezzati M, et al. Global burden of disease and risk factors. New York: Oxford University Press; 2006.
35. World Health Organization. The global burden of disease: 2004 update. 2015. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html. Accessed 12 July 2014.
36. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2197-223.
37. Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012;380:1840-50.
38. Russell LB. Preventing chronic disease: an important investment, but don't count on cost savings. Health Aff. 2009;28:42-5.
39. Zhang NJ, Wan THT, Rossiter LF, et al. Evaluation of chronic disease management on outcomes and cost of care for Medicaid beneficiaries. Health Policy. 2008;86:345-54.
40. Rajgopal R, Cox RH, Lambur M, et al. Cost-benefit analysis indicates the positive economic benefits of the Expanded Food and Nutrition Education Program related to chronic disease prevention. J Nutr Educ Behav. 2002;34:26-37.
41. Irvine L, Barton GR, Gasper AV, et al. Cost-effectiveness of a lifestyle intervention in preventing type 2 diabetes. Int J Technol Assess Health Care. 2011;27:275-82.
42. Guy GP, Yabroff KR, Ekwueme DU, et al. Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Aff. 2014;33:1024-31.
43. Erdem E, Prada SI, Haffer SC. Medicare payments: how much do chronic conditions matter? Medicare Medicaid Res Rev. 2013;3:E1-15.
44. Parekh AK, Kronick R, Tavenner M. Optimizing health for persons with multiple chronic conditions. JAMA. 2014. doi:10.1001/ jama.2014.10181.
45. Ryan JG. Race, risk, and behaviors: race and disproportionate burdens of chronic disease. Clin Therapeutics. 2014;36:464-8.
46. Campbell DJT, Ronksley PE, Manns BJ, et al. The association of income with health behavior change and disease monitoring among patients with chronic disease. PloS One. 2014;9:e94007. doi:10.1371/journal.pone.0094007.
47. World Health Organization. The top 10 causes of death. http://www.who.int/mediacentre/factsheets/fs310/en/index2.html. Accessed 18 July 2014.
48. President of the General Assembly, United Nations. Draft political declaration of the high-level meeting on the prevention and control of non-communicable diseases. http://www.un.org/en/ga/ncdmeeting2011/pdf/NCD_draft_political_declaration.pdf. Accessed 15 July 2014.
49. World Health Organization. Non-communicable diseases and mental health. http://www.who.int/nmh/publications/9789241597418 en/. Accessed 15 July 2014.
50. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA. 2004;29:1238-45.
51. American Association of Clinical Endocrinologists. 2014 AACE/ ACE Consensus Conference of Obesity. http://mms.businesswire. com/media/20140325006164/en/408761/1/aace.pdf [see EC.5. in document]. Accessed 18 July 2014.
52. Harmon P. A glossary of commonly used business process terms. http://www.ispi.org/archives/Glossary/PHarmon.pdf. Accessed 7 Sept 2014.
53. Sturmberg JP. Multimorbidity and chronic disease: an emergent perspective. J Eval Clin Pract. 2014. doi:10.1111/jep.12126.
54. McGrath JW, Winchester MS, Kaawa-Mafigiri D, et al. Challenging the paradigm: anthropological perspectives on HIV as a chronic disease. Med Anthropol. 2014. doi:10.1080/01459740.2014.892483.
55. Higgins JP. Nonlinear systems in medicine. Yale J Biol Med. 2001;75:247-60.
56. Vanuzzo D. The epidemiological concept of residual risk. Intern Emerg Med. 2011;6(Suppl 1):S45-51.
57. Dieci MV, Arnedos M, Delaloge S, et al. Quantification of residual risk of relapse in breast cancer patients optimally treated. Breast. 2013;22:S92-5.
58. Bradbury KE, Appleby PN, Key TJ. Fruit, vegetable, and fiber intake in relation to cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr. 2014;100(suppl 1):394S-8S.
59. Jacka FN, Cherbuin N, Anstey KJ, et al. Dietary patterns and depressive symptoms over time: examining the relationships with socioeconomic positions, health behaviours and cardiovascular risk. PloS One. 2014;9:e87657. doi:10.1371/journal.pone.0087657.
60. Riley TA, Janosky JE. Moving beyond the medical model to enhance primary care. Popul Health Manage. 2012;15:189-93.
61. Sadler LS, Newlin KH, Johnson-Spruill I, et al. Beyond the medical model: interdisciplinary programs of community-engaged health research. Clin Transl Sci. 2011;4:285-97.
62. Dyer AR. The need for a new "New Medical Model": a bio-psychosocial-spiritual model. South Med J. 2011;104:297-8.
63. Buja A, Damiani G, Gini R, et al. Systematic age-related differences in chronic disease management in a population-based cohort study: a new paradigm of primary care is required. PloS One. 2014;9:e91340. doi:10.1371/journal.pone.0091340.
64. Rieck AM. Exploring the nature of power distance on general practitioner and community pharmacist relations in a chronic disease management context. J Interprof Care. 2014. doi:10.3109/13561820.2014.906390.
65. Liddy C, Mill K. An environmental scan of policies in support of chronic disease self-management in Canada. Chr Dis Inj Can. 2014;34:55-63.
66. Simmons LA, Wolever RQ, Bechard EM, et al. Patient engagement as a risk factor in personalized health care: a systematic review of the literature on chronic disease. Genome Med. 2014;6:16-29.
67. Mackenzie L. Can chronic disease management plans including occupational therapy and physiotherapy services contribute to reducing falls risk in older people? Austr Fam Phys. 2014;43:211-5.
68. Brooks AT, Andrade RE, Middleton KR, et al. Social support: a key variable for health promotion and chronic disease management in Hispanic patients with rheumatic diseases. Clin Med Insights Arthr Musculoskel Dis. 2014;7:21-6.
69. Drutchas A, Anandarajah G. Spirituality and coping with chronic disease in pediatrics. Rhode Island Med J. 2014;97:26-30.
70. Vorderstrasse AA, Ginsberg GS, Kraus WE, et al. Health coaching and genomics-potential avenues to elicit behavior change in those at risk for chronic disease: protocol for personalized medicine effectiveness study in Air Force primary care. Global Adv Health Med. 2013;2:26-38.
71. Hussey PS, Schneider EC, Rudin RS, et al. Continuity and the costs of care for chronic disease. JAMA Intern Med. 2014;174:742-8.
72. Jones A, Hedges-Chou J, Bates J, et al. Home telehealth for chronic disease management: selected findings of a narrative synthesis. Telemed e-Health. 2014;20:346-80.
73. Owen N, Salmon J, Koohsari MJ, et al. Sedentary behavior and health: mapping environmental and social contexts to underpin chronic disease prevention. Br J Sports Med. 2014;48:174-7.
74. Shaughnessy AF. Focusing on patient-oriented evidence that matters in the care of patients with diabetes mellitus. Pharmacotherapy. 2004;24:295-7.
75. Wigg AJ, Chinnaratha MA, Wundke R, et al. A chronic disease management model for chronic liver failure. Hepatology. 2014. doi:10.1002/hep.27152.
76. Ritsema TS, Bingenheimer JB, Scholting P, et al. Differences in the delivery of health education to patients with chronic disease by provider type, 2005-2009. Prev Chronic Dis. 2014;11:130175. doi:10.5888/pcd11.130175.
77. Bloem BR, Munneke M. Revolutionising management of chronic disease: the ParkinsonNet approach. BMJ. 2014;348:g1838. doi:http://dx.doi.org/10.1136/bmj.g1838.
78. Bain L, Kennedy C, Archibald D, et al. A training program designed to improve interprofessional knowledge, skills and attitudes in chronic disease settings. J Interprof Care. 2014. doi:10.3109/13561820.2014.898622.
79. Patel KK. Practical and policy implications of a changing health care workforce for chronic disease management. J Ambul Care Manage. 2013;36:302-4.
80. Clarke JL. Preventive medicine: a ready solution for a health care system in crisis. Popul Health Manage. 2010;10:S3-11.